IOL Chemicals and Pharmaceuticals sees revenue growth but faces margin pressure in Q2

IOL Chemicals and Pharmaceuticals sees revenue growth but faces margin pressure in Q2

IOL Chemicals and Pharmaceuticals Limited (IOLCP), a leader in pharmaceutical active pharmaceutical ingredients (APIs) and specialty chemicals, recently reported its financial performance for Q2 FY25, revealing a revenue rise tempered by shrinking margins. In a disclosure to the National Stock Exchange of India and BSE Limited, the company shared key details about its recent earnings, […]

SMS Pharmaceuticals gets EDQM’s CEP approval for Ibuprofen

SMS Pharmaceuticals gets EDQM’s CEP approval for Ibuprofen

SMS Pharmaceuticals Limited said that it has secured certificate of suitability (CEP) approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Ibuprofen. The approval will allow the Indian pharmaceutical company to launch sales of Ibuprofen in the European markets. P. Vamsi Krishna — SMS Pharmaceuticals Executive Director said: “We are […]

Strides Pharma gets FDA approval for Ibuprofen oral suspension

Strides Pharma gets FDA approval for Ibuprofen oral suspension

Strides Pharma Science Limited said that its stepdown fully-owned subsidiary — Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration (FDA) for Ibuprofen Oral Suspension USP, 50 mg/1.25 mL (40 mg/mL) (OTC). The pain drug product from Strides Pharma is the generic of GlaxoSmithKline Consumer Healthcare Holdings (US)’s […]

Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US

Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US

Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg. Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg, are used for alleviating signs and symptoms of rheumatoid arthritis and osteoarthritis. The drug is also used for lowering the risk of developing upper gastrointestinal […]

Alkem Laboratories announces US launch of Ibuprofen and Famotidine Tablets

Alkem Laboratories announces US launch of Ibuprofen and Famotidine Tablets

Alkem Laboratories said that it has launched Ibuprofen and Famotidine Tablets (800 mg/26.6 mg) in the US having secured an approval from the US Food and Drug Administration (FDA). Ibuprofen and Famotidine Tablets is AB-rated generic therapeutic equivalent version of Horizon Medicines’ Duexis Tablets, 800 mg/26.6 mg. According to Alkem Laboratories, it is the first […]